Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis.

Lilja L, Johansson JU, Gromada J, Mandic SA, Fried G, Berggren PO, Bark C.

J Biol Chem. 2004 Jul 9;279(28):29534-41. Epub 2004 Apr 26.

2.

Regulation of the fusion pore conductance during exocytosis by cyclin-dependent kinase 5.

Barclay JW, Aldea M, Craig TJ, Morgan A, Burgoyne RD.

J Biol Chem. 2004 Oct 1;279(40):41495-503. Epub 2004 Jul 23.

3.

Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.

Johansson JU, Lilja L, Chen XL, Higashida H, Meister B, Noda M, Zhong ZG, Yokoyama S, Berggren PO, Bark C.

Brain Res Mol Brain Res. 2005 Aug 18;138(2):215-27.

PMID:
15908038
4.

Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18.

Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL.

J Biol Chem. 1999 Feb 12;274(7):4027-35.

5.

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH.

J Neurosci. 2001 Sep 1;21(17):6758-71.

7.

The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.

Hisanaga S, Saito T.

Neurosignals. 2003 Sep-Oct;12(4-5):221-9. Review.

PMID:
14673209
8.

Cyclin-dependent kinase 5 promotes insulin exocytosis.

Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C.

J Biol Chem. 2001 Sep 7;276(36):34199-205. Epub 2001 Jul 6.

9.

Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.

Odemuyiwa SO, Ilarraza R, Davoine F, Logan MR, Shayeganpour A, Wu Y, Majaesic C, Adamko DJ, Moqbel R, Lacy P.

Immunology. 2015 Apr;144(4):641-8. doi: 10.1111/imm.12416.

10.

Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.

Asada A, Saito T, Hisanaga S.

J Cell Sci. 2012 Jul 15;125(Pt 14):3421-9. doi: 10.1242/jcs.100503. Epub 2012 Mar 30.

12.

Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.

Patzke H, Tsai LH.

J Biol Chem. 2002 Mar 8;277(10):8054-60. Epub 2002 Jan 9.

13.
14.

Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Kobayashi H, Saito T, Sato K, Furusawa K, Hosokawa T, Tsutsumi K, Asada A, Kamada S, Ohshima T, Hisanaga S.

J Biol Chem. 2014 Jul 11;289(28):19627-36. doi: 10.1074/jbc.M113.501148. Epub 2014 May 28.

15.

p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.

Humbert S, Dhavan R, Tsai L.

J Cell Sci. 2000 Mar;113 ( Pt 6):975-83.

16.

Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.

Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY.

J Biol Chem. 2002 Aug 30;277(35):31988-93. Epub 2002 Jun 25.

18.

Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosis.

Amin ND, Zheng YL, Kesavapany S, Kanungo J, Guszczynski T, Sihag RK, Rudrabhatla P, Albers W, Grant P, Pant HC.

J Neurosci. 2008 Apr 2;28(14):3631-43. doi: 10.1523/JNEUROSCI.0453-08.2008.

19.

p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.

Li W, Allen ME, Rui Y, Ku L, Liu G, Bankston AN, Zheng JQ, Feng Y.

J Neurosci. 2016 Nov 2;36(44):11283-11294.

20.

Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.

Ito Y, Asada A, Kobayashi H, Takano T, Sharma G, Saito T, Ohta Y, Amano M, Kaibuchi K, Hisanaga S.

Mol Cell Neurosci. 2014 Jul;61:34-45. doi: 10.1016/j.mcn.2014.05.006. Epub 2014 May 27.

PMID:
24877974

Supplemental Content

Support Center